Can Three Months of Teriparatide Be One of Treatment Options for Osteoporotic Vertebral Compression Fracture Patients?

OBJECTIVE: Osteoporosis is one of the most common causes of vertebral compression fractures (VCFs). Teriparatide, a recombinant human parathyroid hormone, is the first anabolic agent for the treatment of osteoporosis. The aim of this study was to determine whether 3 months of teriparatide could be e...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Korean J Neurotrauma
Hlavní autoři: Kang, Jung Hoon, Yang, Sang Mi, Im, Soo Bin, Jeong, Je Hoon
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Neurotraumatology Society 2019
Témata:
Clinical Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6495587/
https://ncbi.nlm.nih.gov/pubmed/31098345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.13004/kjnt.2019.15.e13
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky